Adaptive Biotechnologies Corporation (FRA:1HM)
Germany
· Delayed Price · Currency is EUR 13.40
-1.16 (-8.00%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Minimal Residual Disease - Service | 133.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Minimal Residual Disease - Service Growth | 29.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immune Medicine - Service | 19.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immune Medicine - Service Growth | -19.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immune Medicine - Collaboration | 13.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immune Medicine - Collaboration Growth | -68.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Minimal Residual Disease - Regulatory Milestone | 12.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sequencing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sequencing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Support | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Support Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regulatory Milestones | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regulatory Milestones Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 178.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 5.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|